Portfolio Portfolio. G-Quadruplex DNA as a Macromolecular Target for Semi-Synthetic Isoflavones Bearing B-Ring Tosylation Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model Synthesis and Evaluation of Bithiazole Derivatives As Potential α-Sarcoglycan Correctors The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2: A repurposing study ROS-Scavenging Selenofluoxetine Derivatives Inhibit in Vivo Serotonin Reuptake Amino-Acid-Anthraquinone Click Chemistry Conjugates Selectively Target Human Telomeric G-Quadruplexes Combining Electrospray Mass Spectrometry (ESI-MS) and Computational Techniques in the Assessment of G-Quadruplex Ligands: A Hybrid Approach to Optimize Hit Discovery Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations Selenoxide elimination triggers enamine hydrolysis to primary and secondary amines: A combined experimental and theoretical investigation Enhanced G-quadruplex selectivity of flavonoid glycoside rutin over quercetin Combinatorial library generation, molecular docking and molecular dynamics simulations for enhancing the isoflavone scaffold in phosphodiesterase inhibition A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) Design 9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop-2-yne-1-yl]anthracene: Synthesis and g-quadruplex selectivity Fluoxetine scaffold to design tandem molecular antioxidants and green catalysts
